dr. chang on the trinova-1 trial in ovarian cancer
Published 11 years ago • 193 plays • Length 0:47Download video MP4
Download video MP3
Similar videos
-
1:58
dr. monk on the design and results of the trinova-1 trial
-
2:43
dr. moore on the impact of solo-1 in ovarian cancer
-
1:19
dr. thigpen on ovarian cancer agents not approved by the fda
-
0:54
dr. karam on primary debulking surgery versus neoadjuvant chemotherapy in ovarian cancer
-
1:42
cristi radford on gene panels in ovarian cancer
-
1:30
dr. rao on improving methods of early detection of ovarian cancer
-
59:23
3/31/18 sandy chang - aging or cancer: the telomere connection
-
1:10
skagen & hypog-01 trials: hypofractionated rt in early breast cancer reduces arm lymphedema risk
-
4:23
tils and os in her2 early breast cancer: 10-year updated analysis of the shorther trial
-
1:08
impact of the sinodar-one trial on clinical practice
-
1:53
dr. chagpar on novel agents for neoadjuvant tnbc treatment
-
1:11
the mimosa trial and a novel prognostic factor in breast cancer
-
7:34
frontline sunitinib compared to everolimus in metastatic renal cell carcinoma
-
2:53
neoadjuvant therapy versus surgery for ovarian cancer
-
2:11
hypog01:unicancer phase 3 trial of locoregional hypo vs normo fractionated rt in early breast cancer
-
2:30
clinical trials in breast cancer: pallas, monarch 3 and solar-1
-
2:26
questions following the destiny-breast trials
-
2:22
clinical trial: loxo-783 for breast cancer (nct05307705)
-
3:27
who gets breast cancer recurrences? - with dr tasha